ERBB2 and cancer: Similar to the majority of the oncogene-driven models of cancer in genetically engineered mice (GEMMs)22,23, spontaneous mammary tumours driven by activated rat-neu in the MMTV-NeuT mouse model may not harbour high neo-antigen load24.